Home > Drug Search >
  • company_query: Aprogen
  •   > 
Drug Filter
Status:
Approved (3) BLA Filing (3) Phase Ⅲ (2) Phase Ⅱ (19) Phase Ⅰ (9)
Clinical Stage:
Pending (5) Active (27) Discontinued (1)
Bio-Type:
Coagulation factor (1) Vaccine (16) Recombinant cytokines (1) Whole antibody (6) ADC (1) Fusion protein (1)
Indication:
Non-alcoholic steatohepatitis (1) Anemia (1) Bladder cancer (1) Breast cancer (1) Avian influenza (1) Urogenital cancer (1) HBV infection (1) Alcoholic hepatitis (1) Hepatocellular carcinoma (HCC) (1) HIV infection (4) Influenza virus infection (2) Rabies (1) Afibrinogenaemia (1) Lymphoma (1) Melanoma (3) Haematological disorders (1) Multiple myeloma (MM) (2) Non-Hodgkin’s lymphoma (NHL) (1) Pancreatic cancer (1) Prostate cancer (1) Rheumatoid arthritis (RA) (1) Solid tumours (3) Systemic lupus erythematosus (2) Tuberculosis (1) Yellow fever (1) Influenza A virus infections (1) Anthrax (1) Neuroblastoma (1) Autistic disorder (1) Malaria (1) Hemophilia A (1) Neutropenia (2) Hematological cancer (1) Glioblastoma (1) Respiratory syncytial virus infection (2) Ebola virus disease (EVD) (3)
Country:
Aprv. Year:
2012 (1) 2017 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top